ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
플루옥세틴 시장 규모는 향후 몇 년 동안 안정적으로 성장할 것으로 예상됩니다. 2029년에는 연평균 성장률(CAGR) 4.4%로 12억 3,000만 달러로 성장할 것입니다. 예측 기간의 성장은 정신건강 프로그램에 대한 정부의 노력과 자금 지원, 정신건강 증진을 위한 공중 보건 캠페인, 소셜 미디어 플랫폼에서 정신건강 문제에 대한 논의와 인식 증가, 온라인 약국의 부상, 정신건강 문제를 받아들이고 대처하는 문화적 변화에 기인합니다. 대처하는 문화적 변화 등에 기인한다고 볼 수 있습니다. 예측 기간 동안의 주요 동향으로는 조기 발견을 위한 진단 방법의 발전, 원격의료의 부상, 약물전달 시스템의 발전, 신약 개발에서 AI와 머신러닝의 활용 확대, 약리유전체학의 발전 등을 꼽을 수 있습니다.
향후 5년간 4.4%의 성장률 전망은 지난번 예측보다 0.3% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 인도와 이스라엘에서 생산되는 플루옥세틴의 제네릭 캡슐과 복제약의 가격을 인상함으로써 미국의 정신건강 치료를 저해할 수 있으며, 그 결과 항우울제 구입 가격이 하락하고 정신과 의료비가 상승할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 느껴질 것입니다.
정신질환 유병률의 증가는 향후 플루옥세틴 시장 확대를 견인할 것으로 예상됩니다. 정신건강 장애는 인지 기능, 정서 기능, 행동 기능에 영향을 미치고 일상생활에 고통과 장애를 초래하는 광범위한 증상을 포괄합니다. 이러한 질병 증가의 요인으로는 사회적 압력, 경제적 문제, 라이프스타일의 변화, 인지 및 진단의 향상 등을 꼽을 수 있습니다. 플루옥세틴은 기분과 감정 조절에 중요한 뇌 내 세로토닌 농도를 높여 증상을 완화시켜 정신질환 치료에 활용되고 있습니다. 예를 들어, 2022년 11월에 영국 정부 투자 의료 시스템인 National Health Service가 실시한 조사에 따르면, 2022년에는 7세에서 16세 아동 중 약 18.0%, 17세에서 24세 청소년 중 약 22.0%가 정신장애를 앓고 있는 것으로 밝혀졌습니다. 특히 17-19세 청소년의 정신장애 유병률은 2021년 17.4%에서 2022년 25.7%로 증가했습니다. 그 결과, 정신 질환의 유병률 증가는 플루옥세틴 시장의 성장을 촉진하는 중요한 요인으로 작용하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 플루옥세틴 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 플루옥세틴 시장 : 성장률 분석
세계의 플루옥세틴 시장 실적 : 규모와 성장, 2019-2024
세계의 플루옥세틴 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 플루옥세틴 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 플루옥세틴 시장 제형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
태블릿
솔루션
캡슐
시럽
기타 제형
세계의 플루옥세틴 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
기타 투여 경로
세계의 플루옥세틴 시장 인구통계별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
성인용
소아
노인
세계의 플루옥세틴 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
강박장애
공황장애
우울증
신경성 폭식증
기타 용도
세계의 플루옥세틴 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
클리닉
병원
기타 최종사용자
세계의 플루옥세틴 시장 : 하위 세분화 태블릿(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
레귤러 태블릿
서방정
세계의 플루옥세틴 시장 : 하위 세분화 솔루션(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 용액
세계의 플루옥세틴 시장 : 하위 세분화 캡슐, 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
표준 캡슐
지연 방출 캡슐
세계의 플루옥세틴 시장 : 하위 세분화 시럽(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구 시럽
세계의 플루옥세틴 시장 : 하위 세분화 기타 제형(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
주사제
국소 형식
제7장 지역별·국가별 분석
세계의 플루옥세틴 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 플루옥세틴 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
플루옥세틴 시장 : 경쟁 구도
플루옥세틴 시장 : 기업 개요
Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
Hetero Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Torrent Pharmaceuticals GmbH
Aurobindo Pharma
Cadila Pharmaceuticals Ltd.
Dr. Reddy's Laboratories Limited
Apotex Inc.
Amneal Pharmaceuticals Inc.
Lupin Ltd.
Glenmark Pharmaceuticals Inc.
Alvogen
Alembic Pharmaceuticals Limited
Accord Healthcare Ltd.
PERRIGO Company plc
Wockhardt Ltd.
Jubilant Life Sciences Ltd.
Lannett Company Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
플루옥세틴 시장 2029 : 새로운 기회를 제공하는 국가
플루옥세틴 시장 2029 : 새로운 기회를 제공하는 부문
플루옥세틴 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Fluoxetine, classified as a selective serotonin reuptake inhibitor (SSRI), is widely utilized as an antidepressant and for various psychiatric conditions. Its mechanism involves boosting serotonin levels, a neurotransmitter crucial for regulating mood, emotions, and behavior in the brain. Prescribed commonly for depression, fluoxetine aids in enhancing sleep, appetite, and energy levels among individuals with major depressive disorder.
Fluoxetine is available in diverse forms such as tablets, solutions, capsules, and syrups. Tablets, a solid oral dosage form, dissolve in the stomach upon ingestion and are administered to adults, children, and the elderly. This medication is frequently prescribed for conditions including obsessive-compulsive disorder, panic disorder, depression, and bulimia nervosa. It is utilized across various settings such as clinics and hospitals.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The fluoxetine market research report is one of a series of new reports from The Business Research Company that provides fluoxetine market statistics, including fluoxetine industry global market size, regional shares, competitors with a fluoxetine market share, detailed fluoxetine market segments, market trends and opportunities, and any further data you may need to thrive in the fluoxetine industry. This fluoxetine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The fluoxetine market size has grown steadily in recent years. It will grow from $0.99 billion in 2024 to $1.03 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increased rates of depression and anxiety disorders, enhanced awareness and de-stigmatization of mental health issues, improved healthcare infrastructure, an aging global population, and the availability of cost-effective generic fluoxetine.
The fluoxetine market size is expected to see steady growth in the next few years. It will grow to $1.23 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to government initiatives and funding for mental health programs, public health campaigns promoting mental well-being, increasing discussion and awareness of mental health issues on social media platforms, the rise of online pharmacies, cultural shifts towards accepting and addressing mental health issues. Major trends in the forecast period include advances in diagnostic methods leading to early detection, the rise of telemedicine facilitates, advances in drug delivery systems, AI and machine learning are increasingly used in drug discovery and development, and developments in pharmacogenomics.
The forecast of 4.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. mental health treatment by inflating prices of generic fluoxetine capsules and oral solutions manufactured in India and Israel, resulting in reduced antidepressant affordability and higher psychiatric care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of mental health disorders is anticipated to drive the expansion of the fluoxetine market in the future. Mental health disorders encompass a wide spectrum of conditions affecting cognitive, emotional, and behavioral functions, resulting in distress or impairment in daily life. Factors contributing to the rise in these disorders include societal pressures, economic challenges, lifestyle shifts, and improved awareness and diagnosis. Fluoxetine is utilized in the treatment of mental health disorders because it alleviates symptoms by enhancing serotonin levels in the brain, crucial for regulating mood and emotions. For example, a survey conducted in November 2022 by the National Health Service, a UK government-funded healthcare system, revealed that approximately 18.0% of children aged 7 to 16 and 22.0% of young individuals aged 17 to 24 potentially had a mental disorder in 2022. Specifically, the prevalence of likely mental disorders among young people aged 17 to 19 increased from 17.4% in 2021 to 25.7% in 2022. Consequently, the rising prevalence of mental health disorders is a significant factor propelling the growth of the fluoxetine market.
The fluoxetine market is anticipated to experience growth due to the rise in healthcare expenditure. This increase is driven by factors such as the escalating costs of advanced medical technologies, aging populations, and the prevalence of chronic diseases. As healthcare spending rises, it improves the accessibility and affordability of medications such as fluoxetine, which benefits patients requiring treatment for depression and anxiety disorders by enhancing access and adherence. Consequently, this can lead to better mental health outcomes overall and reduce long-term healthcare expenses. For example, in January 2024, healthcare expenditure in the US surged by 4.1% in 2022 to $4.5 trillion, marking a faster growth rate compared to the 3.2% increase seen in 2021, as reported by the National Institutes of Health, a US government agency.
Key players in the fluoxetine market are concentrating on innovating products such as fluoxetine tablets for treating various mental health disorders such as major depressive disorder. Fluoxetine tablets contain fluoxetine hydrochloride, an antidepressant classified as a selective serotonin reuptake inhibitor (SSRI). In April 2024, Strides Pharma Global Pte. Limited, a Singapore-based pharmaceutical company, received approval from the United States Food and Drug Administration (USFDA) for Fluoxetine Tabs 10 mg and 20 mg. This approval expands the company's fluoxetine product line by introducing tablets alongside the already-approved capsules. Fluoxetine, an SSRI, is used to treat conditions such as major depressive disorder (MDD), obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder with or without agoraphobia. The introduction of fluoxetine tablets broadens the treatment options within the company's fluoxetine portfolio, providing patients and healthcare providers with more flexibility and choices in managing these mental health disorders.
Major companies operating in the fluoxetine market are Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hetero Ltd., Torrent Pharmaceuticals GmbH, Aurobindo Pharma, Cadila Pharmaceuticals Ltd., Dr. Reddy's Laboratories Limited, Apotex Inc., Amneal Pharmaceuticals Inc., Lupin Ltd., Glenmark Pharmaceuticals Inc., Alvogen, Alembic Pharmaceuticals Limited, Accord Healthcare Ltd., PERRIGO Company plc, Wockhardt Ltd., Jubilant Life Sciences Ltd., Lannett Company Inc., Mayne Pharma International Pty Ltd., Par Pharmaceutical Companies Inc., Zydus Pharmaceuticals USA Inc., Ascend Laboratories LLC
North America was the largest region in the fluoxetine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluoxetine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the fluoxetine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The fluoxetine market consists of sales of fluoxetine hydrochloride tablets, fluoxetine powder, and fluoxetine injection. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Fluoxetine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on fluoxetine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for fluoxetine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The fluoxetine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Dosage Form: Tablet; Solution; Capsule; Syrup; Other Dosage Forms
2) By Route Of Administration: Oral; Other Routes Of Administration
3) By Demographic: Adult; Pediatric; Geriatric
4) By Application: Obsessive-Compulsive Disorder; Panic Disorder; Depression; Bulimia Nervosa; Other Applications
5) By End User: Clinic; Hospital; Other End Users
Subsegments:
1) By Tablet: Regular Tablets; Extended-Release Tablets
2) By Solution: Oral Solution
3) By Capsule: Standard Capsules; Delayed-Release Capsules
4) By Syrup: Oral Syrup
5) By Other Dosage Forms: Injection Form; Topical Form
Companies Mentioned: Eli Lilly and Company; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Hetero Ltd.; Torrent Pharmaceuticals GmbH; Aurobindo Pharma; Cadila Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Limited; Apotex Inc.; Amneal Pharmaceuticals Inc.; Lupin Ltd.; Glenmark Pharmaceuticals Inc.; Alvogen; Alembic Pharmaceuticals Limited; Accord Healthcare Ltd.; PERRIGO Company plc; Wockhardt Ltd.; Jubilant Life Sciences Ltd.; Lannett Company Inc.; Mayne Pharma International Pty Ltd.; Par Pharmaceutical Companies Inc.; Zydus Pharmaceuticals USA Inc.; Ascend Laboratories LLC
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Fluoxetine Market Characteristics
3. Fluoxetine Market Trends And Strategies
4. Fluoxetine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Fluoxetine Growth Analysis And Strategic Analysis Framework
5.1. Global Fluoxetine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fluoxetine Market Growth Rate Analysis
5.4. Global Fluoxetine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fluoxetine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fluoxetine Total Addressable Market (TAM)
6. Fluoxetine Market Segmentation
6.1. Global Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablet
Solution
Capsule
Syrup
Other Dosage Forms
6.2. Global Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Other Routes Of Administration
6.3. Global Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adult
Pediatric
Geriatric
6.4. Global Fluoxetine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Obsessive-Compulsive Disorder
Panic Disorder
Depression
Bulimia Nervosa
Other Applications
6.5. Global Fluoxetine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinic
Hospital
Other End Users
6.6. Global Fluoxetine Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Regular Tablets
Extended-Release Tablets
6.7. Global Fluoxetine Market, Sub-Segmentation Of Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Solution
6.8. Global Fluoxetine Market, Sub-Segmentation Of Capsule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Capsules
Delayed-Release Capsules
6.9. Global Fluoxetine Market, Sub-Segmentation Of Syrup, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Syrup
6.10. Global Fluoxetine Market, Sub-Segmentation Of Other Dosage Forms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection Form
Topical Form
7. Fluoxetine Market Regional And Country Analysis
7.1. Global Fluoxetine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fluoxetine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Fluoxetine Market
8.1. Asia-Pacific Fluoxetine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Fluoxetine Market
9.1. China Fluoxetine Market Overview
9.2. China Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Fluoxetine Market
10.1. India Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Fluoxetine Market
11.1. Japan Fluoxetine Market Overview
11.2. Japan Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Fluoxetine Market
12.1. Australia Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Fluoxetine Market
13.1. Indonesia Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Fluoxetine Market
14.1. South Korea Fluoxetine Market Overview
14.2. South Korea Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Fluoxetine Market
15.1. Western Europe Fluoxetine Market Overview
15.2. Western Europe Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Fluoxetine Market
16.1. UK Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Fluoxetine Market
17.1. Germany Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Fluoxetine Market
18.1. France Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Fluoxetine Market
19.1. Italy Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Fluoxetine Market
20.1. Spain Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Fluoxetine Market
21.1. Eastern Europe Fluoxetine Market Overview
21.2. Eastern Europe Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Fluoxetine Market
22.1. Russia Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Fluoxetine Market
23.1. North America Fluoxetine Market Overview
23.2. North America Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Fluoxetine Market
24.1. USA Fluoxetine Market Overview
24.2. USA Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Fluoxetine Market
25.1. Canada Fluoxetine Market Overview
25.2. Canada Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Fluoxetine Market
26.1. South America Fluoxetine Market Overview
26.2. South America Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Fluoxetine Market
27.1. Brazil Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Fluoxetine Market
28.1. Middle East Fluoxetine Market Overview
28.2. Middle East Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Fluoxetine Market
29.1. Africa Fluoxetine Market Overview
29.2. Africa Fluoxetine Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Fluoxetine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Fluoxetine Market, Segmentation By Demographic, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Fluoxetine Market Competitive Landscape And Company Profiles
30.1. Fluoxetine Market Competitive Landscape
30.2. Fluoxetine Market Company Profiles
30.2.1. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Hetero Ltd. Overview, Products and Services, Strategy and Financial Analysis
31. Fluoxetine Market Other Major And Innovative Companies
31.1. Torrent Pharmaceuticals GmbH
31.2. Aurobindo Pharma
31.3. Cadila Pharmaceuticals Ltd.
31.4. Dr. Reddy's Laboratories Limited
31.5. Apotex Inc.
31.6. Amneal Pharmaceuticals Inc.
31.7. Lupin Ltd.
31.8. Glenmark Pharmaceuticals Inc.
31.9. Alvogen
31.10. Alembic Pharmaceuticals Limited
31.11. Accord Healthcare Ltd.
31.12. PERRIGO Company plc
31.13. Wockhardt Ltd.
31.14. Jubilant Life Sciences Ltd.
31.15. Lannett Company Inc.
32. Global Fluoxetine Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Fluoxetine Market
34. Recent Developments In The Fluoxetine Market
35. Fluoxetine Market High Potential Countries, Segments and Strategies
35.1 Fluoxetine Market In 2029 - Countries Offering Most New Opportunities
35.2 Fluoxetine Market In 2029 - Segments Offering Most New Opportunities
35.3 Fluoxetine Market In 2029 - Growth Strategies
